Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Stomach Cancer and Gastric Cancer Drugs
1.2 Key Market Segments
1.2.1 Stomach Cancer and Gastric Cancer Drugs Segment by Type
1.2.2 Stomach Cancer and Gastric Cancer Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Stomach Cancer and Gastric Cancer Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Stomach Cancer and Gastric Cancer Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Stomach Cancer and Gastric Cancer Drugs Market Competitive Landscape
3.1 Global Stomach Cancer and Gastric Cancer Drugs Sales by Manufacturers (2019-2024)
3.2 Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Stomach Cancer and Gastric Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Stomach Cancer and Gastric Cancer Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Stomach Cancer and Gastric Cancer Drugs Sales Sites, Area Served, Product Type
3.6 Stomach Cancer and Gastric Cancer Drugs Market Competitive Situation and Trends
3.6.1 Stomach Cancer and Gastric Cancer Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Stomach Cancer and Gastric Cancer Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Stomach Cancer and Gastric Cancer Drugs Industry Chain Analysis
4.1 Stomach Cancer and Gastric Cancer Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Stomach Cancer and Gastric Cancer Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Stomach Cancer and Gastric Cancer Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Type (2019-2024)
6.3 Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Stomach Cancer and Gastric Cancer Drugs Price by Type (2019-2024)
7 Stomach Cancer and Gastric Cancer Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Stomach Cancer and Gastric Cancer Drugs Market Sales by Application (2019-2024)
7.3 Global Stomach Cancer and Gastric Cancer Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Stomach Cancer and Gastric Cancer Drugs Sales Growth Rate by Application (2019-2024)
8 Stomach Cancer and Gastric Cancer Drugs Market Segmentation by Region
8.1 Global Stomach Cancer and Gastric Cancer Drugs Sales by Region
8.1.1 Global Stomach Cancer and Gastric Cancer Drugs Sales by Region
8.1.2 Global Stomach Cancer and Gastric Cancer Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Stomach Cancer and Gastric Cancer Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Stomach Cancer and Gastric Cancer Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Stomach Cancer and Gastric Cancer Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Stomach Cancer and Gastric Cancer Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Stomach Cancer and Gastric Cancer Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Ipsen Pharma
9.1.1 Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Basic Information
9.1.2 Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Product Overview
9.1.3 Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.1.4 Ipsen Pharma Business Overview
9.1.5 Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs SWOT Analysis
9.1.6 Ipsen Pharma Recent Developments
9.2 Merck and Co., Inc.
9.2.1 Merck and Co., Inc. Stomach Cancer and Gastric Cancer Drugs Basic Information
9.2.2 Merck and Co., Inc. Stomach Cancer and Gastric Cancer Drugs Product Overview
9.2.3 Merck and Co., Inc. Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.2.4 Merck and Co., Inc. Business Overview
9.2.5 Merck and Co., Inc. Stomach Cancer and Gastric Cancer Drugs SWOT Analysis
9.2.6 Merck and Co., Inc. Recent Developments
9.3 Bristol-Myers Squibb Company
9.3.1 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Basic Information
9.3.2 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Product Overview
9.3.3 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.3.4 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs SWOT Analysis
9.3.5 Bristol-Myers Squibb Company Business Overview
9.3.6 Bristol-Myers Squibb Company Recent Developments
9.4 Eli Lilly
9.4.1 Eli Lilly Stomach Cancer and Gastric Cancer Drugs Basic Information
9.4.2 Eli Lilly Stomach Cancer and Gastric Cancer Drugs Product Overview
9.4.3 Eli Lilly Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.4.4 Eli Lilly Business Overview
9.4.5 Eli Lilly Recent Developments
9.5 Roche
9.5.1 Roche Stomach Cancer and Gastric Cancer Drugs Basic Information
9.5.2 Roche Stomach Cancer and Gastric Cancer Drugs Product Overview
9.5.3 Roche Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 Novartis AG
9.6.1 Novartis AG Stomach Cancer and Gastric Cancer Drugs Basic Information
9.6.2 Novartis AG Stomach Cancer and Gastric Cancer Drugs Product Overview
9.6.3 Novartis AG Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.6.4 Novartis AG Business Overview
9.6.5 Novartis AG Recent Developments
9.7 Bayer AG
9.7.1 Bayer AG Stomach Cancer and Gastric Cancer Drugs Basic Information
9.7.2 Bayer AG Stomach Cancer and Gastric Cancer Drugs Product Overview
9.7.3 Bayer AG Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.7.4 Bayer AG Business Overview
9.7.5 Bayer AG Recent Developments
9.8 Celltrion Inc.
9.8.1 Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Basic Information
9.8.2 Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Product Overview
9.8.3 Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.8.4 Celltrion Inc. Business Overview
9.8.5 Celltrion Inc. Recent Developments
9.9 TAIHO PHARMACEUTICAL CO., LTD.
9.9.1 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Basic Information
9.9.2 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Product Overview
9.9.3 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.9.4 TAIHO PHARMACEUTICAL CO., LTD. Business Overview
9.9.5 TAIHO PHARMACEUTICAL CO., LTD. Recent Developments
9.10 Jiangsu Hengrui Medicine Co., Ltd.
9.10.1 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Basic Information
9.10.2 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Product Overview
9.10.3 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Product Market Performance
9.10.4 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
9.10.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
10 Stomach Cancer and Gastric Cancer Drugs Market Forecast by Region
10.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size Forecast
10.2 Global Stomach Cancer and Gastric Cancer Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Region
10.2.4 South America Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Stomach Cancer and Gastric Cancer Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Stomach Cancer and Gastric Cancer Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Stomach Cancer and Gastric Cancer Drugs by Type (2025-2030)
11.1.2 Global Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Stomach Cancer and Gastric Cancer Drugs by Type (2025-2030)
11.2 Global Stomach Cancer and Gastric Cancer Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Stomach Cancer and Gastric Cancer Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Stomach Cancer and Gastric Cancer Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
